FindTrial
Sign In

A prospective study for the expectant management pf placental polyp

A prospective study for the expectant management pf placental polyp - The expectant management study

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000024472
Enrollment
50
Registered
2016-12-01
Start date
2017-02-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

placental popyp

Interventions

In case of PDCS up-regulation or increasing of hCG level during the expectant management for placental polyp, we consider the intervention with uterine artery embloization after differential diagnosis

Sponsors

Nagoya University Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: The patients, who are diagnosed placental polyp after delivery or termination of pregnancy. There is no preference of the duration after the termination and mass diameter.

Exclusion criteria

Exclusion criteria: The case white the physician judge to be inappropriate.

Design outcomes

Primary

MeasureTime frame
Th eplacental polyp is examined mass diameter and PDCS using ultrasonography. We check Hb and hCG level in blood test. The patients take the examinations once a week. The expctant management protocol aim that placental polyp show PDCS level1 and hCG level show under-sensitive.—

Countries

Japan

Contacts

Public ContactSachiko TAKIKAWA

Nagoya University Graduate School of Medicine Department of Obstetrics and Gynecology

stone24@med.nagoya-u.ac.jp052-744-2261

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026